MyFinsight
Home
Blog
About
Contact
Download
Download image
Net comprehensive
loss
-$26,556K
Change in fair value of
warrant liability
-$2,021K
(-134.83%↓ Y/Y)
Interest income
$1,012K
(-19.75%↓ Y/Y)
Net loss
-$26,555K
(27.70%↑ Y/Y)
Unrealized loss on
marketable securities, net
$1K
Total other income
(expenses)
$2,962K
(164.22%↑ Y/Y)
Interest expense
$71K
(0.00%↑ Y/Y)
Loss from operations
-$29,517K
(8.10%↑ Y/Y)
Total operating
expenses
$29,517K
(-8.10%↓ Y/Y)
General and
administrative
$20,396K
(68.52%↑ Y/Y)
Research and development
$9,121K
(-54.43%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Unicycive Therapeutics, Inc. (UNCY)
Unicycive Therapeutics, Inc. (UNCY)